Biotechnology firm Bristol Myers Squibb (NYSE: BMY) Friday reported larger revenues and web revenue for the second quarter of 2024.
Web revenue attributable to shareholders was $1.68 billion or $0.83 per share within the June quarter, in comparison with $2.07 billion or $0.99 per share within the comparable interval of 2023. Adjusted revenue rose to $2.07 per share in Q2 from $1.75 per share within the prior yr interval.
Second-quarter revenues elevated 9% from final yr to $12.2 billion. Home revenues elevated by 13%, whereas worldwide revenues edged down 1%.
